[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 123,708,720
  • Shares Outstanding, K 2,041,735
  • Annual Sales, $ 48,194 M
  • Annual Income, $ 7,054 M
  • EBIT $ 12,645 M
  • EBITDA $ 16,656 M
  • 60-Month Beta 0.27
  • Price/Sales 2.44
  • Price/Cash Flow 7.08
  • Price/Book 6.34

Options Overview Details

View History
  • Implied Volatility 28.21% (+0.95%)
  • Historical Volatility 30.55%
  • IV Percentile 28%
  • IV Rank 37.74%
  • IV High 40.88% on 11/19/25
  • IV Low 20.52% on 12/31/25
  • Expected Move (DTE 6) 1.56 (2.69%)
  • Put/Call Vol Ratio 0.99
  • Today's Volume 43,729
  • Volume Avg (30-Day) 21,697
  • Put/Call OI Ratio 0.90
  • Today's Open Interest 573,397
  • Open Int (30-Day) 542,360
  • Expected Range 56.66 to 59.78

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 31 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.64
  • Number of Estimates 9
  • High Estimate $1.71
  • Low Estimate $1.60
  • Prior Year $1.46
  • Growth Rate Est. (year over year) +12.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
57.22 +1.75%
on 04/15/26
60.78 -4.21%
on 04/30/26
-3.51 (-5.69%)
since 04/01/26
3-Month
54.96 +5.93%
on 02/02/26
62.89 -7.42%
on 03/02/26
+3.17 (+5.76%)
since 01/30/26
52-Week
42.52 +36.92%
on 10/29/25
62.89 -7.42%
on 03/02/26
+8.61 (+17.36%)
since 05/01/25

Most Recent Stories

More News
BMY Q1 Deep Dive: Growth Portfolio, Pipeline Milestones, and Anticipated Late-Stage Readouts

BMY Q1 Deep Dive: Growth Portfolio, Pipeline Milestones, and Anticipated Late-Stage Readouts

BMY : 58.22 (-3.91%)
Bristol-Myers Squibb (NYSE:BMY) Exceeds Q1 CY2026 Expectations

Bristol-Myers Squibb (NYSE:BMY) Exceeds Q1 CY2026 Expectations

BMY : 58.22 (-3.91%)
Bristol Myers Squibb Reports First Quarter Financial Results for 2026

Bristol Myers Squibb (NYSE: BMY) today reported first quarter 2026 financial results. Visit the company’s Investor Relations website at http://investor.bms.com ...

BMY : 58.22 (-3.91%)
Bristol-Myers Squibb's Pipeline Narrative Meets Its Patent Cliff Reality

Barchart Research What to Expect from BMY Earnings BMY Generated April 29, 2026 Current Price $57.59 EPS Estimate $$1.44 Consensus Rating Moderate Buy Average Move 5.78% Bristol-Myers Squibb's Pipeline...

BMY : 58.22 (-3.91%)
Do Wall Street Analysts Like Bristol-Myers Squibb Stock?

Although Bristol-Myers Squibb has lagged behind the SPX over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

XLV : 145.16 (-0.57%)
$SPX : 7,230.12 (+0.29%)
BMY : 58.22 (-3.91%)
Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q1 Results Tomorrow

Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q1 Results Tomorrow

BMY : 58.22 (-3.91%)
3 Biotech Stocks That Could Benefit from the Patent Cliff

Biotech M&A is surging ahead of a $300B patent cliff. Here are 3 gene-editing stocks investors are watching as potential acquisition targets

BEAM : 30.70 (+1.22%)
CRSP : 51.63 (-1.36%)
MRK : 112.16 (+2.73%)
BMY : 58.22 (-3.91%)
NTLA : 13.26 (-1.63%)
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company

Expands Options for Cash-Paying Patients to Access the Nation’s #1 Prescribed Oral Blood Thinner

PFE : 26.33 (-1.39%)
BMY : 58.22 (-3.91%)
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration

SAN DIEGO , April 23, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) (the "Company"), a biopharmaceutical company dedicated to delivering RNA therapeutics directly to the heart, announced...

RNA : 13.43 (+5.17%)
BMY : 58.22 (-3.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers...

See More

Key Turning Points

3rd Resistance Point 61.58
2nd Resistance Point 60.83
1st Resistance Point 59.53
Last Price 58.22
1st Support Level 57.47
2nd Support Level 56.72
3rd Support Level 55.42

See More

52-Week High 62.89
Last Price 58.22
Fibonacci 61.8% 55.11
Fibonacci 50% 52.70
Fibonacci 38.2% 50.30
52-Week Low 42.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.